               SEQUENCE LISTING

<110> Vaxeal Holding SA

<120> Immunogenic Compositions

<130> P117354

<160> 15

<170> BiSSAP 1.3

<210> 1
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S1 positions 17-34

<400> 1
His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
1               5                   10                  15      
Cys Thr 
        

<210> 2
<211> 27
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S2 positions 84-110

<400> 2
Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu Thr Leu Gly 
1               5                   10                  15      
Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys 
            20                  25          

<210> 3
<211> 21
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S3 positions 122-142

<400> 3
Lys Glu Phe Glu Glu Thr Ala Lys Lys Val Arg Arg Ala Ile Glu Gln 
1               5                   10                  15      
Leu Ala Ala Met Asp 
            20      

<210> 4
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S1 positions 17-31

<400> 4
His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys 
1               5                   10                  15  

<210> 5
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S1 positions 20-34

<400> 5
Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala Cys Thr 
1               5                   10                  15  

<210> 6
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S2 positions 84-98

<400> 6
Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu Thr Leu 
1               5                   10                  15  

<210> 7
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S2 positions 90-104

<400> 7
Lys Lys Gln Phe Glu Glu Leu Thr Leu Gly Glu Phe Leu Lys Leu 
1               5                   10                  15  

<210> 8
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S2 positions 93-107

<400> 8
Phe Glu Glu Leu Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu 
1               5                   10                  15  

<210> 9
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S2 positions 96-110

<400> 9
Leu Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys 
1               5                   10                  15  

<210> 10
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S3 positions 122-136

<400> 10
Lys Glu Phe Glu Glu Thr Ala Lys Lys Val Arg Arg Ala Ile Glu 
1               5                   10                  15  

<210> 11
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> alpha-isoform survivin S3 positions 128-142

<400> 11
Ala Lys Lys Val Arg Arg Ala Ile Glu Gln Leu Ala Ala Met Asp 
1               5                   10                  15  

<210> 12
<211> 26
<212> DNA
<213> Artificial Sequence

<220> 
<223> Chemically synthesized oligonucleotide - Litenimod

<400> 12
taaacgttat aacgttatga cgtcat                                         26


<210> 13
<211> 24
<212> DNA
<213> Artificial Sequence

<220> 
<223> Chemically synthesised oligonucleotide - CpG 2006

<400> 13
tcgtcgtttt gtcgttttgt cgtt                                           24


<210> 14
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Chemically synthesized oligonucleotide - CpG 2336

<400> 14
ggggacgacg tcgtgggggg g                                              21


<210> 15
<211> 142
<212> PRT
<213> Homo sapiens

<220> 
<223> Alpha-isolform Survivin

<400> 15
Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      
His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          
Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              
Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  
Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys His 
65                  70                  75                  80  
Ser Ser Gly Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu 
                85                  90                  95      
Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn Lys 
            100                 105                 110         
Ile Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr Ala 
        115                 120                 125             
Lys Lys Val Arg Arg Ala Ile Glu Gln Leu Ala Ala Met Asp 
    130                 135                 140         

